QIX Dividenden Europa
16 583,29
|
19,71
|
0,12 %
|
Analysen zu QIX Dividenden Europa-Werten
13.02.25 | VINCI Buy | Jefferies & Company Inc. | |
12.02.25 | VINCI Buy | UBS AG | |
12.02.25 | Hennes & Mauritz AB Hold | Deutsche Bank AG | |
12.02.25 | VINCI Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.02.25 | Iberdrola Buy | UBS AG | |
11.02.25 | VINCI Outperform | RBC Capital Markets | |
10.02.25 | GSK Hold | Deutsche Bank AG | |
10.02.25 | VINCI Buy | Deutsche Bank AG | |
10.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
10.02.25 | Roche Outperform | Bernstein Research | |
07.02.25 | VINCI Overweight | JP Morgan Chase & Co. | |
07.02.25 | GSK Outperform | Bernstein Research | |
07.02.25 | VINCI Buy | Deutsche Bank AG | |
07.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
07.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
07.02.25 | VINCI Buy | Goldman Sachs Group Inc. | |
07.02.25 | Allianz Buy | Goldman Sachs Group Inc. | |
06.02.25 | VINCI Buy | UBS AG | |
06.02.25 | VINCI Overweight | JP Morgan Chase & Co. | |
06.02.25 | VINCI Outperform | RBC Capital Markets | |
06.02.25 | Hannover Rück Buy | Jefferies & Company Inc. | |
06.02.25 | Hannover Rück Kaufen | DZ BANK | |
06.02.25 | TotalEnergies Outperform | RBC Capital Markets | |
06.02.25 | Hannover Rück Outperform | RBC Capital Markets | |
06.02.25 | GSK Hold | Deutsche Bank AG | |
06.02.25 | Hannover Rück Neutral | UBS AG | |
06.02.25 | Hannover Rück Overweight | JP Morgan Chase & Co. | |
06.02.25 | TotalEnergies Buy | UBS AG | |
06.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
06.02.25 | GSK Neutral | UBS AG | |
06.02.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
05.02.25 | TotalEnergies Overweight | JP Morgan Chase & Co. | |
05.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
05.02.25 | GSK Outperform | Bernstein Research | |
05.02.25 | GSK Neutral | UBS AG | |
05.02.25 | TotalEnergies Outperform | RBC Capital Markets | |
05.02.25 | Allianz Buy | Deutsche Bank AG | |
05.02.25 | TotalEnergies Buy | UBS AG | |
05.02.25 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
05.02.25 | GSK Underweight | JP Morgan Chase & Co. |